Eventide Asset Management, LLC 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 11:55 am Sale |
2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Eventide Asset Management, LLC | 42,499 0.100% |
-2,795,626![]() (-98.50%) |
Filing |
2021-02-12 4:11 pm Purchase |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Eventide Asset Management, LLC | 2,838,125 8.000% |
2,838,125![]() (New Position) |
Filing |